Funded Tech Companies
QL Biopharm
QL Biopharm is a biopharmaceutical tech venture, based in Beijing. Financial backing came from OrbiMed, Qiming Ventures and Taiyu Capital.
Company Overview
Company Name
QL Biopharm
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Building 7, No. 20, Life Science Park Road, Changping Distri 101
Beijing, 102206
China
Beijing, 102206
China
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Founded in September 2018, Tripeptide Biotech focuses on producing recombinant protein drugs using E. coli and is committed to developing innovative biopharmaceuticals to treat chronic metabolic diseases (such as diabetes, obesity, and non-alcoholic steatohepatitis) and improve people's quality of life. Currently, the biopeptide pipeline has 10 recombinant protein innovative drugs and biosimilars under development, including two independently developed Class I innovative drugs and one domestically produced international blockbuster biosimilar that has entered the clinical trial stage. The core members of the Peptide Biotechnology R&D team come from well-known domestic and international pharmaceutical companies such as Novo Nordisk, Bayer, and Gan & Lee, and have accumulated extensive experience in biopharmaceuticals. The company currently possesses a complete industry chain from drug development and pilot-scale amplification to commercialization.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/2/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Zhang Xujia
Chief Operating Officer
Wu Ning
Co-Founder
Zhai Peng
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs